Cargando…

Advanced Hepatocellular Carcinoma Tumor Stage at Diagnosis in the 1945‐1965 Birth Cohort Reflects Poor Use of Hepatocellular Carcinoma Screening

Individuals from the 1945‐1965 birth cohort account for the majority of hepatocellular carcinoma (HCC) cases in the United States. Understanding trends in HCC among this birth cohort is vital given the increasing burden of chronic liver disease among this group. We retrospectively evaluated trends a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robinson, Ann, Tavakoli, Hesam, Liu, Benny, Bhuket, Taft, Wong, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128228/ https://www.ncbi.nlm.nih.gov/pubmed/30202827 http://dx.doi.org/10.1002/hep4.1236

Ejemplares similares

One in five hepatocellular carcinoma patients in the United States are Hispanic while less than 40% were eligible for liver transplantation
por: Robinson, Ann, et al.
Publicado: (2018)

2212. Preliminary Screening Results Outside the 1945–1965 Birth Cohort: A Forgotten Population for HCV?
por: Winetsky, Daniel, et al.
Publicado: (2018)

Preliminary Screening Results Outside the 1945–1965 Birth Cohort: A Forgotten Population for Hepatitis C?
por: Winetsky, Daniel, et al.
Publicado: (2019)

Moderne Musik 1945-1965 :Voraussetzungen, Verlauf, Material, Mit 3l Abbildungen und 45 Notenbeispielen
por: Dibelius, Ulrich
Publicado: (1966)

Results of a Hepatitis C Virus Screening Program of the 1945–1965 Birth Cohort in a Large Emergency Department in New Jersey
por: Cornett, Julia Kang, et al.
Publicado: (2018)

Liver cancer: A leading cause of cancer death in the United States and the role of the 1945–1965 birth cohort by ethnicity
por: Pinheiro, Paulo S., et al.
Publicado: (2019)

Bibliografía peruana de ciencias sociales publicada en inglés 1945-1965
por: Vázquez, Mario Carlos, 1926-
Publicado: (1967)

Serum miR-224 Reflects Stage of Hepatocellular Carcinoma and Predicts Survival
por: Zhuang, Li-ping, et al.
Publicado: (2015)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

Hepatitis C virus screening practices and seropositivity among US veterans born during 1945 – 1965
por: Cartwright, Emily J, et al.
Publicado: (2014)

Zwischen Staat und Selbstverwaltung: die deutsche Forschung im Wiederaufbau, 1945-1965
por: Stamm, Thomas
Publicado: (1981)

A Proof of Concept Study Demonstrating the Feasibility of a Text Message Prompt for Hepatitis C Testing in the 1945-1965 Birth Cohort
por: Fisk, Rebecca J, et al.
Publicado: (2019)

920. Automated Hepatitis C Screening and Linkage to Care among Hospitalized Patients Born Between 1945-1965
por: Gasior, Julia A, et al.
Publicado: (2021)

Encounter with disaster: a medical diary of Hiroshima, 1945. Condensed from the original publication, 1965.
por: Liebow, A. A.
Publicado: (1983)

Comparison of Staging Systems of Hepatocellular Carcinoma
por: Sirivatanauksorn, Yongyut, et al.
Publicado: (2011)

Screening for Hepatocellular Carcinoma
por: Lui, Hock-Foong
Publicado: (2011)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
por: Zhong, Cheng‐Qian, et al.
Publicado: (2018)

VEGF Overexpression Predicts Poor Survival in Hepatocellular Carcinoma
por: Choi, Sae Byeol, et al.
Publicado: (2017)

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
por: Margetts, Jane, et al.
Publicado: (2018)

Dyskerin Overexpression in Human Hepatocellular Carcinoma Is Associated with Advanced Clinical Stage and Poor Patient Prognosis
por: Liu, Bei, et al.
Publicado: (2012)

Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis
por: Sun, Quanquan, et al.
Publicado: (2020)

Current staging of hepatocellular carcinoma: imaging implications
por: Bhosale, P, et al.
Publicado: (2006)

Hepatocellular carcinoma: early-stage management challenges
por: Erstad, Derek J, et al.
Publicado: (2017)

Management of patients with intermediate stage hepatocellular carcinoma
por: Prince, David, et al.
Publicado: (2020)

The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma
por: Rico Montanari, Noe, et al.
Publicado: (2021)

Improving hepatitis C screening and diagnosis in patients born between 1945 and 1965 in a safety-net primary care clinic
por: Bakhai, Smita, et al.
Publicado: (2019)

Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
por: ZHANG, ZHEN-HAI, et al.
Publicado: (2014)

Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
por: Luo, Rongzhen, et al.
Publicado: (2013)

The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis
por: Ha, Sang Yun, et al.
Publicado: (2016)

Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma
por: Zhang, Xinyuan, et al.
Publicado: (2017)

Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma
por: Chen, Jiewei, et al.
Publicado: (2018)

Comment on ‘Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?’
por: Liu, Yuying, et al.
Publicado: (2018)

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
por: Chen, Yibing, et al.
Publicado: (2018)

Ornithine transcarbamylase downregulation is associated with poor prognosis in hepatocellular carcinoma
por: He, Lin, et al.
Publicado: (2019)

Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
por: Ding, Qinglin, et al.
Publicado: (2022)

Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

Hepatocellular carcinoma: development and early detection
por: Robinson, Philip
Publicado: (2008)

Circulating tumor cells undergoing EMT are poorly correlated with clinical stages or predictive of recurrence in hepatocellular carcinoma
por: Chen, Yunyang, et al.
Publicado: (2019)

Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients
por: Zhang, Xiang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fj3hrsovh0as8ph4hsk483j0k2